PDCD1 and neoplasm: When PD-1 on activated cytotoxic T lymphocytes (CTL) binds to its ligand PD-L1 on the membranes of tumor cells and macrophages in the tumor tissues, immune checkpoint-induced inhibition signals shut down the CTL antitumor immune activity [2].